NASDAQ: NK       Nantkwest Inc CS
Last Price Today's Change   Day's Range   Trading Volume
17.25   -0.54 (3.04%)  16.59 - 20.05  1,765,804


Avg Volume (4 weeks):4,894,438
4 Weeks Range:10.23 - 20.05
4 Weeks Price Volatility (%):
52 Weeks Range:2.52 - 20.05
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S territories.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2866  3553  210  3252 

Top 10 Active Counters
 SNDL 0.708+0.018 
 BNGO 7.81+0.86 
 CCIV 18.22+0.86 
 LK 1.38+1.38 
 CTRM 0.332-0.028 
 AMC 2.399+0.219 
 BB 9.715+0.605 
 AVGR 1.59+0.48 
 OBSV 4.185+1.665 
 NIO 55.925-4.945 


1. Equities Retreated on Waning Optimism State of The Markets
2. Daily Futures Trading Strategy 15 January 2021 Where Futures Lies
3. CryptoNews of the Week CryptoNews
4. Markets Mixed on Hedging State of The Markets
5. Impeachment, Stimulus And The Markets Wall Street Breakfast